GlassScriptPhysician profile
Gary P Goodfried
NPI 1750379061
$147,004.70
in general payments reported to CMS, 2019-2025
4 companies · $6,320 in 2025
The $6,320 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $36K · 2021: $29K · 2022: $16K · 2023: $13K · 2024: $8,227 · 2025: $6,320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $27K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $27,248.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $145,031.46 | 2019-2025 | Lps |
| Stryker Corporation | $1,769.85 | 2019-2022 | |
| Wound Management Technologies, INC | $113.44 | 2019 | |
| Boston Scientific Corporation | $89.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Goodfried listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.